Pharmacy Drugs
Recent Posts
- Malignant Brain Tumors: Chemotherapy Alone Is Just As Effective As Radiation / New Positive Prognostic Factor Found
- Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
- Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint In A Phase II Clinical Trial In Type 2 Diabetic Patients
- Largest Clinical Trial To Test Benefits Of Aspirin In Australia
- University Of Florida To Receive $29.5 Million In Recovery Act Funds To Begin Study Of Whether Exercise Prevents Disability In Older Adults
Random Posts
- FDA Approves Iloperidone for Schizophrenia
- Acceleron To Present ACE-031 Preclinical Study Results As Treatment For Loss Of Muscle Mass And Function
- Unique Collaboration Between TB Alliance And Tibotec To Accelerate Tuberculosis Drug Development
- Pluristem Therapeutics Receives European Regulatory Approval For Placental-Derived Stem Cell Clinical Trial
- Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint In The First Phase III Clinical Trial
- Bayer And Onyx Initiate Phase 3 Trial Of Nexavar In Patients With Non-Responsive Thyroid Cancer
- Shire Submits European Marketing Authorization Application (MAA) For Velaglucerase Alfa For The Treatment Of Type 1 Gaucher Disease
- FDA: Dental Amalgam Safe But Should Include Warning
- Mckesson Corporation Signs On As Leadership Supporter For ASHP's Pharmacy Practice Model Initiative
- Does Glutathione-S-Transferase Associate With Gastrointestinal Cancer In The Korean Population?
Royal Pharmaceutical Society Responds To Concerns Over Human Swine Flu, UK
Posted by: admin in Pharmacy, Pharmacy Drugs on May 04th, 2009
The Royal Pharmaceutical Society responded to concerns about the human swine flu virus H1N1 and stressed the vital role pharmacists play in public health.
The Society’s Director of Policy and Communications David Pruce said:
“At present, we are keeping a watching brief on the situation. Should the need arise, pharmacists will receive further information and guidance as part of the Department of Health’s strategy to deal with an influenza pandemic.
“Community pharmacists have always played a key role in public health. As trusted health professionals, they are ideally placed to provide straightforward, high quality information and advice to worried patients.
“Testing has shown that the virus can be treated with antivirals, and pharmacists should reiterate that it is good practice to follow respiratory and hand hygiene advice such as:
- Covering your nose and mouth when coughing or sneezing, using a tissue when possible.
- Disposing of dirty tissues promptly and carefully.
- Maintaining good basic hygiene, for example washing hands frequently with soap and water to reduce the spread of the virus from your hands to face or to other people.
- Cleaning hard surfaces (eg. door handles) frequently using a normal cleaning product.
- Making sure children follow this advice.
“Individuals returning from affected areas who become unwell within seven days of their return should stay at home and contact their GP or NHS Direct for further advice.”
The symptoms of swine influenza in people are similar to the symptoms of regular human seasonal influenza infection and include fever, fatigue, lack of appetite, coughing and sore throat. Some people with swine flu have also reported vomiting and diarrhoea. For more detail, please contact the Health Protection Agency http://www.hpa.org.uk
Source
Royal Pharmaceutical Society
Further information on Swine Flu
- See a Map Of H1N1 Outbreaks
- See our Mexico Swine Flu Blog
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.